Item 9 Labs Corp. (INLB)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 23, 2026
0.00%
Market Cap 702.00
Revenue (ttm) 19.69M
Net Income (ttm) -31.03M
Shares Out 701.81M
EPS (ttm) -0.32
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 418
Average Volume 5,745
Open 0.0000
Previous Close n/a
Day's Range 0.0000 - 0.0000
52-Week Range 0.0000 - 0.0000
Beta 0.15
RSI 25.80
Earnings Date n/a

About Item 9 Labs

Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. It operates through Cultivation, Franchising, and Corporate segments. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd ... [Read more]

Sector Healthcare
Employees 104
Stock Exchange OTCMKTS
Ticker Symbol INLB
Full Company Profile

Financial Performance

In fiscal year 2022, Item 9 Labs's revenue was $21.76 million, a decrease of -0.82% compared to the previous year's $21.94 million. Losses were -$31.14 million, 185.6% more than in 2021.

Financial Statements

News

There is no news available yet.